News

Essity Expands Portfolio with Edgewell's Feminine Care Brands

Essity Expands Portfolio with Edgewell's Feminine Care Brands

Essity Enhances Presence in Feminine Care Market

Hygiene and health company Essity, based in Sweden, has made a strategic move by acquiring Edgewell Personal Care's feminine care business. This acquisition includes well-known brands such as Carefree, Stayfree, and Playtex, establishing Essity's significant footprint in North America’s hygiene market, which is the largest in the world.

Details of the Acquisition

The total price for the acquisition is set at USD 340 million, which reflects Essity's focus on high-margin categories and strategic growth in key markets. This deal encompasses Edgewell's renowned feminine care offerings, which feature products like liners, pads, and tampons. Additionally, it comprises a production facility located in Dover, Delaware.

Comments from Leadership

Ulrika Kolsrud, President and CEO of Essity, expressed her enthusiasm for the acquisition, noting that it aligns with the company's strategy to reinforce its position in personal care. According to her, this expansion enables the growth of well-established brands by leveraging Essity's success formula within the feminine care sector.

Financial Insights

In terms of financial performance, the acquired business reported net sales of approximately USD 261 million for the 12 months ending mid-2025, highlighting its viability and market relevance. Moreover, it boasts a segment operating profit estimated at USD 17 million during the same period. The purchase price implies an EBITDA multiple of about 12.1x based on pro-forma IFRS figures, decreasing to 8.3x when factoring in expected synergies post-acquisition.

Workforce and Production

The feminine care division under Edgewell employs around 500 individuals, with the majority situated at the Dover production facility. This workforce integration will undoubtedly bolster Essity's operational capacity within the feminine care segment.

Future of Essity in North America

The acquisition transaction is yet to receive customary regulatory approvals, but it is anticipated to close in early 2026. Essity is recognized as a dynamic player in the feminine care space, already boasting a portfolio of strong regional brands including Libresse and Bodyform.

Upcoming Events and Investor Engagement

As part of its commitment to transparency, Essity will host an audio webcast including a presentation by its leadership team. This event is scheduled for November 13 and will provide insights on the acquisition and Essity's future directions in the market.

Frequently Asked Questions

What brands are included in the acquisition by Essity?

The acquisition includes Carefree, Stayfree, o.b., and Playtex brands, enhancing Essity's feminine care offerings.

What is the total financial value of the acquisition?

The total purchase price for Edgewell's feminine care business is USD 340 million.

When is the expected completion date for the acquisition?

The acquisition is anticipated to finalize in the first quarter of 2026, pending regulatory approvals.

How will this acquisition benefit Essity?

This acquisition strengthens Essity's market position in North America, aligning with its strategy to focus on high-margin categories.

What other brands does Essity offer in the feminine care market?

Essity's portfolio includes other recognized brands like Libresse, Bodyform, Nana, Saba, Libra, and Nosotras, providing a wide range of feminine hygiene products.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 5

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 3

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 7

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 5

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 4

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 3

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 3

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 7

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading

Top 5 Most Recently Viewed Articles

Celebrating the Pioneers: Results of the 2025 Belonging Awards

Updated Category News Views 242

Introduction to the 2025 Belonging Awards The 2025 Belonging Awards stand as a testament to organizations dedicated to fostering an inclusive workplace. This year, the awards, organized by the Employer Branding Institute, saw a remarkable competition among companies globally, showcasing their commitment to Diversity, Equity, and Inclusion (DEI). The extensive evaluation...

Continue Reading
AI Innovations Driving Growth in Hypothyroidism Market

Updated Category News Views 183

The Growing Hypothyroidism Market and Its Innovations The global hypothyroidism market is on the brink of significant expansion, with projections indicating a remarkable growth of USD 789.8 million over the upcoming years. This growth is fueled by innovative advancements and strategic approaches within the healthcare sector. The market is expected to exhibit an impressive...

Continue Reading
Richmond Heights Celebrates 75 Years with Inspiring Stories

Updated Category News Views 273

Celebating 75 Years of Richmond Heights The Richmond Heights community recently came together for a significant milestone, marking 75 years of rich history and cultural diversity. The celebration was not only about the past; it was a heartfelt acknowledgment of the leaders who have molded this extraordinary place over decades. A Tribute to Community Leaders This special...

Continue Reading
Investigation Launched into Dyne Therapeutics Over Stock Drop

Updated Category News Views 82

Investigation Launched into Dyne Therapeutics Following Stock Decline Dyne Therapeutics, Inc. (NASDAQ: DYN), recognized for its groundbreaking approaches to treating muscular dystrophy, is currently facing scrutiny as Bronstein, Gewirtz & Grossman, LLC has initiated an investigation into potential claims on behalf of investors. This action follows some concerning news...

Continue Reading
Taseko Mines: Highlights from Q1 Earnings Report and Future Plans

Updated Category News Views 211

Insight into Taseko Mines Limited's Q1 2025 Performance Taseko Mines Limited (TSX: TKO; NYSE American: TGB; LSE: TKO), based in Vancouver, British Columbia, is making waves in the mining sector with its compelling first quarter earnings report for 2025. The company disclosed an Adjusted EBITDA of $34 million and earnings from mining operations before depletion and...

Continue Reading